Aurora Cannabis (ACB) Accounts Payables (2018 - 2026)

Aurora Cannabis (ACB) has reported Accounts Payables for 9 consecutive years, with $41.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Accounts Payables fell 29.97% year-over-year to $41.1 million in Q2 2026; TTM through Jun 2026 was $41.1 million, a 29.97% decrease from a year earlier, with the FY2026 full-year figure at $36.6 million, down 30.86% from the prior year.
• Accounts Payables was $41.1 million for Q2 2026 at Aurora Cannabis, up from $36.9 million in the prior quarter.
• Over five years, Accounts Payables peaked at $74.1 million in Q3 2022 and troughed at $28.6 million in Q3 2024.
• A 5-year average of $46.8 million and a median of $46.1 million in 2023 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables soared 71.03% in 2022 and sank 48.97% in 2023, its largest moves.
• Over 5 years, Accounts Payables stood at $56.2 million in 2022, then slipped by 18.49% to $45.8 million in 2023, then gained by 9.39% to $50.1 million in 2024, then fell by 2.59% to $48.8 million in 2025, then declined by 15.78% to $41.1 million in 2026.
• The last three Accounts Payables figures came in at $41.1 million (Q2 2026), $36.9 million (Q1 2026), and $48.8 million (Q4 2025), per Business Quant data.